ViBone in Cervical and Lumbar Spine Fusion

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

118 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-14

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assess clinical and radiographic outcomes in patients who undergo 1-3 level anterior cervical discectomy fusion (ACDF) or lumbar interbody fusion (TLIF, PLIF, ALIF, or LLIF) using ViBone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study Evaluating 3-Level OLIF Spine Fusion

NCT03896347

Spondylolisthesis Retrolisthesis Degenerative Disc Disease

WITHDRAWN

Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

NCT00726128

Trauma Tumor Pseudarthrosis +2 more

COMPLETED

An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix

NCT02814825

Cervical Spondylosis Degenerative Intervertebral Discs Herniated Disc

COMPLETED

BIO4 Clinical Case Study: Cervical Spine

NCT03077204

Degenerative Disc Disease Trauma (Including Fractures) Spondylolisthesis

COMPLETED PHASE4

Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™

NCT01615328

Intervertebral Disk Degeneration Intervertebral Disk Displacement Ossification of Posterior Longitudinal Ligament

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a prospective, multi-center study to evaluate the clinical and radiographic outcomes of ViBone in patients undergoing ACDF or lumbar interbody fusion. Data will be gathered for subjects undergoing ACDF surgery and subjects undergoing lumbar fusion surgery using ViBone. Total enrollment is expected to be approximately 100 subjects. The purpose of this study is to assess clinical and radiographic outcomes in patients who undergo 1-3 level ACDF or lumbar interbody fusion surgery using ViBone. Subjects will be followed for 12 months following surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spondylosis Cervical Spondylosis Spondylolisthesis Herniated Nucleus Pulposus Degenerative Disc Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cervical Fusion - ACDF

Patients undergoing anterior cervical discectomy and fusion (ACDF) using ViBone will be enrolled.

ViBone

Intervention Type OTHER

Viable Bone Allograft

Lumbar Interbody Fusion

Patients undergoing lumbar interbody fusion (TLIF, PLIF, ALIF, or LLIF) using ViBone will also be enrolled.

ViBone

Intervention Type OTHER

Viable Bone Allograft

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ViBone

Viable Bone Allograft

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, 18-80 years of age
* For cervical cases - ACDF surgery at 1, 2, or 3 contiguous levels between C2-C7
* For lumbar cases - lumbar interbody fusion surgery at 1, 2, or 3 contiguous levels between L1-S1
* Patient signed Consent Form with HIPAA Authorization
* Appropriate candidate for surgery
* Patient will adhere to the scheduled follow-up visits and requirements of the protocol including routine patient exams - pre-operative, operative, and at least two post- operative visits (6 and 12 months post-surgery). Pre-operative and post-operative visits include X-ray (required) and CT scan (if available).

Exclusion Criteria

* Long term use of medications that are known to inhibit fusion or bone metabolism or immune suppressants 6 months prior to surgery (i.e., steroids, chemotherapy, DMARDs, etc.)
* Treatment with radiotherapy
* Acute or chronic systemic or localized spinal infections
* Instability associated with major reconstructive surgery for primary tumors or metastatic malignant tumors of the cervical (for ACDF patients) or lumbar (for TLIF, PLIF, ALIF, or LLIF patients) spine
* Previous pseudoarthrosis at any level of the cervical (for ACDF patients) or lumbar (for
* TLIF, PLIF, ALIF, or LLIF patients) spine
* Nursing mothers or women who are pregnant or plan to become pregnant during the course of the study
* Current or recent history of malignancy or infectious disease. Patients with current or recent history of basal cell carcinoma are eligible.
* Inability to provide informed consent
* Rapid joint disease, bone absorption, osteomalacia, and/or diagnosed osteoporosis (bone density score of ≤-2.5).
* Other medical or surgical conditions which would preclude the potential benefit of surgery, such as congenital abnormalities, immunosuppressive disease, elevation of sedimentation rate unexplained by other diseases, elevation of white blood count (WBC), or marked left shift in the WBC differential count.
* Active local or systemic infection or is undergoing adjunctive treatment for local or systemic infection.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No